A Crazy factoid: All small bio go down the day of their earnings call. I am not sure why as everyone knows that they don't make any money. I often trade off of this phenomenon. I plan to buy some more CEMP tomorrow if it is down.
Everything is on point. All great news with the trials . All the BIG boys were there. Huge interest from the big trading houses. This thing is going to run soon.
Huh? With the average volume they have 13 days to cover. Obviously on good news the volume triples or more and they cover in 3 days. I am in the camp there is no bad news coming before NDA. I feel the short hedges are very smart and started their shorts at the peak between 27 and 30 and will be covering before or in September. The good bio's are acting good now even with Russian problems.
Summer volume and also ,most think there are no near term catalysts but they are wrong. Teksta protocol will be soon and urinary phase 111 starting soon. Funds know that no news is good news with CEMP as phase 111 is 70% complete with no hiccups. My guess is funds will start buying heavily from Sept. in to December . There is no competition in phase 111 trials. TTPH is a good compliment investment with CEMP but Im not positive their drug will be successful orally . TTPH will be needed for resistant gram negative and urinary strains none the less.
Could be simple as 80% of the short position was initiated at $30. If this is the case then they have a nice cushion for profit so their trigger point where they cover may be $24 or so. You have to think that they and everyone else just assumed a 10% market correction was due this year so even though that didn't happen the bio's did correct and they safely made a nice profit.
Yea. I have read the full reports from the top 4 analysts covering ACAD and they go in to detail as to why they think the fair price of ACAD is now and what they expect the PPS to be 2 yrs out and it is very impressive. The market has a short memory I guess. Anything under $21 before Nov. is a good price IMHO. CEMP is very undervalued right now as well.
LOl. If someone is paying you to post, they are not getting much for their money.
Congrats. CEMP is the only bio on my list that is under priced. The only reason it is discounted is because of what happened to Telithromycin. CEMP does not inhibit the alpha-7 acetylcholine nicotinic receptor; such inhibition is believed responsible for certain adverse effects observed with telithromycin . CEMP will move fast in September unless it is bought out by then.
Congrats to you! Yes. I loaded up under 8.80. I was hoping to get some in high 7"s but CEMP held up like a rock on the 17th . I have some $ left in case there is a 500 point melt down in the market and CEMP gets in 7"s. I was a bit impatient and bought from 12 all the way down but Im still happy. Im pretty much locked and loaded as TAKSTA phase 111 protocol is any day now and phase 111 genital infection should be announced soon. And who knows…..they could get bought out for $27 at any time.
Yea….He is a Rookie. I do not believe the good bio stocks in phase 111 will sell off much unless market corrects 7%. Bio has already corrected a lot and the good companies are close to bargain prices. Look at CEMP for a double in 6 months.
No kidding. With ACAD market cap they would be silly not to. Its not like it is real cheap. 21-26 is probably fair value until November.
Like he can make a difference in the PPS…lol Though Im sure short funds do hire board posters. I don't know how anyone can take a job that dosnt serve mankind ,but thats life.
No CEO,No Pro Athlete,No movie Stars deserve what they get. I wish people would vote boards out, stop going to movies,stop watching Pro Sports. It costs $180 to take kids to watch a ball game now. It sucks to just see people taking advantage.
I picked the pig of the bunch as did those buying the $14 offering.
Good and bad in everything. She may have saved a rookie to sell who was in a bad bio, and she enabled me to get a great bio on the cheap in CEMP. Her picking on a sector ( though she said small bio) was a rookie mistake. You know people saw her speech in advance and the bio sector corrected the week before the speech. So now the bio sector is way over sold. Also a concern is I believe Govnt officials can still trade stocks on info they are voting on etc. USA is more like a " Banana Republic" than we know.